Haemonetics Corp. buy Needham & Company LLC
Start price
03.12.24
/
50%
€80.50
Target price
03.12.25
€106.36
Performance (%)
-43.85%
Price
02.09.25
€45.20
Summary
This prediction is currently active. Massive losses of -43.85% have been the result for the BUY prediction by Needham___Company_LL. This prediction currently runs until 03.12.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | -1.299% | -1.299% |
| iShares Core DAX® | -2.458% | 0.524% |
| iShares Nasdaq 100 | -1.226% | 1.491% |
| iShares Nikkei 225® | -1.984% | 3.351% |
| iShares S&P 500 | -0.767% | 2.346% |
Comments by Needham___Company_LL for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Needham___Company_LL for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€49.00
07.08.25
07.08.25
€58.31
07.08.26
07.08.26
-7.76%
02.09.25
02.09.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€60.00
08.05.25
08.05.25
€74.16
08.05.26
08.05.26
-24.67%
02.09.25
02.09.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€58.50
18.03.25
18.03.25
€95.28
18.03.26
18.03.26
-22.74%
02.09.25
02.09.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.00
07.02.25
07.02.25
€104.18
07.02.26
07.02.26
-20.70%
02.09.25
02.09.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€84.00
15.11.24
15.11.24
€106.41
15.11.25
15.11.25
-46.19%
02.09.25
02.09.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€79.00
12.06.24
12.06.24
€103.42
12.06.25
12.06.25
-24.68%
13.06.25
13.06.25